If you are wondering whether IDEXX Laboratories is still fairly priced after a strong run, this article walks through what the current share price could mean for long term investors. The stock last ...

The majority of Idexx's revenue comes from its Companion Animal Group, a segment that includes diagnostic products for vets.

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership ...

WESTBROOK, Maine, Feb. 15, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that seamlessly ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the ...

IDEXX Laboratories, Inc. (IDXX) is a multinational healthcare company specializing in the development, manufacture, and ...

Idexx Laboratories (IDXX) reported $1.11 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.6%. EPS of $3.63 for the same period compares to $2.44 a year ...

IDEXX Laboratories, Inc. (IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return. The last ...

For the quarter ended September 2024, Idexx Laboratories (IDXX) reported revenue of $975.54 million, up 6.6% over the same period last year. EPS came in at $2.80, compared to $2.53 in the year-ago ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...